
T-Rex 2X Long NVIDIA Daily Target ETF (NVDX)
Dividend History
Pay Date | Amount | Ex-Date | Record Date |
---|---|---|---|
December 26, 2024 | $2.17 | 2024-12-24 | 2024-12-24 |
Dividends Summary
- T-Rex 2X Long NVIDIA Daily Target ETF has issued 1 dividend payments over the past 0 years
- The most recent dividend was paid 268 days ago, on December 26, 2024
- The highest dividend payed out to investors during this period was $2.167763 per share
- The average dividend paid during this period was $2.17 per share.
Company News
We highlight a bunch of the best-performing leveraged equity ETFs from different corners of the market that are leaders in their segments for the first half.
Please think twice before attempting to juice your investment returns with this risky tool.
The CNBC host has been right about Nvidia, says a fund manager who had started a fund to bet against his calls.
An ETF that generated headlines in October 2022 is shutting down. The ETF gave investors a way to bet against investor and television personality Jim Cramer. Here are the details and why the decision to shut the fund was made. What Happened: First announced in October 2022, Tuttle Capital launched two ETFs to track the stock picks of Cramer. One was to the long side betting on his stock picks made on television and X and one was to the short side betting against the picks made by Cramer, commonly known as Inverse Cramer. The Long Cramer ETF was shut down in September 2023 and the Inverse Cramer now follows the same path. On Thursday, it was announced that the Northern Lights Fund Trust IV Inverse Cramer ETF (BATS:SJIM) will be shutting down and liquidating. The board of trustees of the fund determined liquidation was in the best interest of shareholders. The last day of trading for the ETF will be Feb. 13. The fund is expected to distribute proceeds to shareholders on Feb. 23. "We started (the fund) in order to point out the danger of following TV stockpickers, Jim Cramer specifically, and the total lack of accountability," Tuttle ...Full story available on Benzinga.com